| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.1M | -6.1% |
| R&D Expense | $54.9M | +2.8% |
| SG&A Expense | $26.1M | +17.4% |
| Operating Income | -$73.0M | -8.8% |
| Net Income | -$58.3M | +7.6% |
| EPS (Basic) | -$1.32 | +13.2% |
| EPS (Diluted) | -$1.32 | +13.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | -62.7% |
| Short-term Investments | $324.8M | +17.9% |
| Accounts Receivable | $0 | — |
| Current Assets | $349.2M | +5.1% |
| Total Assets | $380.4M | +4.5% |
| Current Liabilities | $13.0M | -21.0% |
| Total Liabilities | $36.1M | -16.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | -17.8% |
| Capital Expenditures | $1.9M | -71.3% |
| Investing Cash Flow | -$41.2M | -170.7% |
| Financing Cash Flow | $59.5M | — |
| Free Cash Flow | -$52.4M | -6.2% |
| Stockholders' Equity |
| $344.3M |
| +7.4% |